This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a ceiling value of $317,609.46 and a period of performance through November 19, 2024. The award is unrestricted, meaning Teva competed as a large business without any set-aside designations. Teva is a major pharmaceutical supplier to federal agencies, including the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons, and Indian Health Service, and has received numerous federal contract awards for the delivery of critical pharmaceutical products such as vaccines, antiviral medications, and treatments for conditions like multiple sclerosis. This contract supports military immunization programs and is part of Teva's role in maintaining reliable access to essential medications for federal healthcare programs through long-term, large-scale contracts, including Indefinite Delivery Contracts (IDCs) with the VA and DLA.
Generated 2/13/25, 9:32 AM